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This excellent atlas is based on the autlhor's
experience with over 11,000 liver biopsies.
There is a brief chapter on techniques of
obtaining and processing the biopsy. The
main chapter considers the various abnormal
morplhological features that may be encoun-
tered (alterations in lobular architecture,
portal tracts, liver cells, etc.) and their pos-
sible significaiice. A shorter clhapter describes
how these individual features may be com-
bined in the major liver diseases (hepatitis,
cirrhosis, etc.). There are excellent, bibliog-
raplhies, and ani appendix ofstaining methods.
However, the value of this atlas is in its
excellent colour photomicrographs these are
uniforml,y informative, and the standard of
reproduction is very true to life. The diagnosis
of neoplasia is not one of the major problems
for the pathologist dealing with liver biopsies,
and this aspect of liver pathology is only
briefly dealt -with. But, this atlas can con-
fidently be recommended as a practical guide
to histopathology; unfortunately its price is
likely to prove somewhat daunting.
0. G. DODGE
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COChIRAN (1979) London: Acadernic Press.
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The production of a book dealing solely
with studies in man relating to immunliological
aspects of the tumour-host relationslhip is a
daunting task. The number of studies whicl
are unequivocally consistent, with the concept
that progression to malignant disease is
accompanied by the expression of novel anti-
genic components against which the host is
capable of mounting an effective imnmuno-
logical reaction are indeed few%N. The field
abounds -with controversy, and in spite of a
massive effort it cannot yet, be stated with
any certainty that the basic premnise oftumour
immunity in man is proven. It is against this
background that this book slhould be assessed.
It provides a reviewr of the somewhat super-
ficial exvidence we have to date of an immune
involvement in the control of malignancy,
and is indeed timely as the subject moves
towards a more in-depth analysis with the
less subjective technolgov that is now be-
coming availalle and wvhich has provided
suclh insight, inito the biology of the immune
system.
The author starts logically wvith clinical
observations suchi as histological appearances,
tumour dormtancy and the association of
malignancy wvith immunosuppression and
age, which are suggestive of a host response
before considering the in vivo and ini vitro
assays wN-hich have been applied to the study
of tumour immunogenicity. This latter
section may appear uncritical at times, with
reference t,o the problems of interpretation of,
for example, cytotoxicity assays and the ready
acceptance of sulchl studies in the establish-
ment of the presence and nat,ure of blocking
factors in patients' sera. Much is also made
of the migrationi-inhibition test, reflecting the
author's interest and involvement, though
again this is a technique which has not gained
universal acceptance as applied t,o the cancer
problem. The presence ofactual test data in a
book of this type is novel, and may be con-
fusing to readers unfamiliar w-ith the assays.
It must be said that much of this section has
appeai-ed previously in the book "Immuno-
logical Aspects of Cancer" edited by J. E.
Castro.
The later sections of the book deal wvith
practical applications of studies of immuno-
logy of cancer patients, and the effects of
ti-eatment, on the immune system. In each
chapter it is point,ed out that the reasons for
the apparent differences bet-ween the cancer
patients and control are poorly understood
and by no means uniform so that the sig-
nificance of these differences is unclear. The
goal of tumour immunology in immuno-
diagnosis and serial monit,oring of disease
progression is as yet unattainable, except in
a few wx-ell defined conditions. The final chap-
ter document,s the attempts to use immuno-
therapy in malignant disease.